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The RNA genome of the human T-cell leukemia virus type 1 (HTLV-1) codes for proteins involved in
infectivity, replication, and transformation. We report in this study the characterization of a novel viral protein
encoded by the complementary strand of the HTLV-1 RNA genome. This protein, designated HBZ (for HTLV-1
bZIP factor), contains a N-terminal transcriptional activation domain and a leucine zipper motif in its C
terminus. We show here that HBZ is able to interact with the bZIP transcription factor CREB-2 (also called
ATF-4), known to activate the HTLV-1 transcription by recruiting the viral trans-activator Tax on the Tax-
responsive elements (TxREs). However, we demonstrate that the HBZ/CREB-2 heterodimers are no more able
to bind to the TxRE and cyclic AMP response element sites. Taking these findings together, the functional
inactivation of CREB-2 by HBZ is suggested to contribute to regulation of the HTLV-1 transcription. Moreover,
the characterization of a minus-strand gene protein encoded by HTLV-1 has never been reported until now.
Human T-cell leukemia virus type 1 (HTLV-1), the etiologic
agent of adult T-cell leukemia and HTLV-1-associated my-
elopathy/tropical spastic paraparesis, is a T-cell-tropic virus
that belongs to the HTLV-bovine leukemia virus (HTLV-
BLV) group of the retrovirus family. Other group members
include HTLV-2, BLV, and the simian T-cell leukemia viruses.
All retroviruses share similarity in their genome organization,
with four genes encoding proteins necessary for the production
of infectious virions, the order of these genes being invariably
gag, pro, pol, env (from 5 to 3) (Fig. 1A). gag codes for
internal structural proteins of the virion, pro codes for the viral
protease, pol codes for reverse transcriptase, and env codes for
envelope glycoproteins of the virion. The expression of the
HTLV-1 genome is controlled by two regulatory genes, the rex
and tax genes, located in the 3 region of the viral genome. Tax
is a potent transactivator of viral transcription (5, 30), and Rex
acts at the posttranscriptional level by modulating the trans-
port of the viral RNAs (14). Moreover, the HTLV-1 genome
carries between the env gene and the 3 long terminal repeat
(LTR) other open reading frames encoding proteins with un-
known functions. All these viral proteins are encoded by the
viral plus-strand RNA.
The trans-activation of the viral transcription by Tax oper-
ates through three 21-bp repeats (6, 28) located in the U3
region of the LTR. These conserved repeats, called Tax-re-
sponsive elements (TxREs), contain an imperfect cyclic AMP
response element (CRE) (17) that is recognized by CREB (4,
37, 38) and CREM (29), two members of the activating tran-
scription factor/CRE-binding protein (ATF/CREB) family.
These factors are characterized by basic leucine zipper (bZIP)
C-terminal structures required for DNA binding and protein
dimerization. To activate transcription of the HTLV-1 ge-
nome, Tax interacts with CREB or CREM bound to the
TxREs (4, 38) and then can recruit the transcriptional coacti-
vator CREB-binding protein (CBP) (21). The recruitment of
CBP to the HTLV-1 promoter could be involved in the acet-
ylation of the core histone tails (7, 11).
Another member of the ATF/CREB family, CREB-2 (20),
also known as ATF-4 (12) or TAXREB 67 (32), cooperates
with the viral Tax protein to enhance the transcription of the
HTLV-1 promoter (9, 27). We have shown that CREB-2 binds
to the TxREs and that CREB-2 binding to each of the 21-bp
motifs is enhanced by Tax (10). In this paper, we report that
CREB-2 is able to interact with a second viral protein that had
never been characterized until now. This novel viral protein is
encoded by the minus-strand RNA that is transcribed by a
functional promoter present in the antisense strand of the
1.8-kb 3 terminus of the HTLV-1 proviral genome containing
the 3 LTR (22). As this protein contains a bZIP domain in its
C-terminal region, we have named it HBZ (for HTLV-1 bZIP
factor). We show here that HBZ contains a transcriptional
activation domain and directly interacts with CREB-2,
CREB-2 and HBZ associating via their bZIP domains. How-
ever, in spite of the presence of an activation domain, HBZ
down-regulates the viral transcription. Indeed, HBZ can act as
a negative regulator of CREB-2-dependent transcription by
forming heterodimers that are unable to bind to the CRE and
TxRE sites.
MATERIALS AND METHODS
Plasmids. The complete HBZ coding region was amplified from cDNA pre-
pared from MT2 cells and cloned into the plasmid pGEX-4T-2 (Pharmacia), and
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the HBZ DNA encoding the different truncated mutants was generated by PCR
amplification on pGEX-HBZ. DNA amplified by PCR was then subcloned into
different vectors: the bacterial expression vector pQE-31 (Qiagen), the eukary-
otic vector pBind (Promega) containing the GAL4 DNA-binding (GAL4 DB)
domain, the eukaryotic expression vector pCI-neo (Promega), and the plasmid
pEGFP-C1 (Clontech). All the different plasmids used during this work and ex-
pressing CREB-2 (pGEX-CREB-2, pGEX-CREB-2263-351, pGEX-CREB-21-262,
pQE-CREB-2, pLEXA-CREB-2263-351, pCI-CREB-2) Tax (pQE-Tax and pSG-
Tax), and Tat (pBg312HIV-1Lai-Tat) have already been described elsewhere
(8–10).
Screening for proteins that interact with the CREB-2 bZIP domain. MT2
cDNA fused to the GAL4 activation domain of the pGAD10 vector (9) was
screened using the CREB-2 bZIP domain as bait fused to the LEXA DNA-
binding domain of the pBTM116 vector. The two-hybrid screen was performed
as already described (9). Briefly, pLEXA-CREB-2 bZIP and the fusion cDNA
library were cointroduced into the L40 Saccharomyces cerevisiae strain by the
lithium acetate method (15). The L40 yeast strain possesses the His synthase
gene (his3) and the lacZ gene under the control of LEXA binding sites. From
approximately 9  106 clones screened, we selected robust colonies growing on
agar medium lacking Trp, Leu, and His, for those that contained both types of
plasmids (Leu and Trp) and that also expressed interacting hybrid proteins
(His). Selected transformants were assayed for the expression of lacZ by the
-galactosidase filter assay as described in the Clontech protocol. Plasmid DNA
of the clones that were strongly positive for -galactosidase activity was ex-
tracted, analyzed by digestion with restriction enzymes, and sequenced.
Expression of HBZ tagged with GFP in COS7 cells. To express HBZ and
HBZbZIP with a green fluorescent protein (GFP) tag, the coding sequences of
both proteins were subcloned into the vector pEGFP-C1. COS7 cells were
transfected using the FuGENE 6-mediated transfection method (Roche) with 4
g of expression vector. Cells were cultivated on the glass slides and then
analyzed by fluorescence 48 h after transfection. Analysis of the green fluores-
cence was performed with a Leica DMR immunofluorescence microscope.
Transfections and luciferase assays. CEM cells were transiently cotransfected
according to the previously published procedure (31). Five micrograms of
pAC1 (-galactosidase-containing reference plasmid) was included in each
transfection for controlling of the transfection efficiency. The total amount of
DNA in each transfection was the same, the balance being made up with empty
plasmids. Cell extracts equalized for protein content were used for luciferase and
-galactosidase assays. For the assays with the GAL4-binding site promoter-
reporter plasmid, the wild-type HBZ and the truncated mutants fused in frame
with the GAL4 DB domain into the vector pBIND were cotransfected in CEM
cells in the presence of the luciferase reporter plasmid pG5luc containing five
GAL4 binding sites upstream of a minimal TATA box.
Protein expression and purification. The bacterial expression vectors pQE
containing either the HBZ bZIP domain, CREB-2, or Tax cDNA inserts were
transformed into Escherichia coli M15. The N-terminal six-His-tagged proteins
FIG. 1. The HTLV-1 genome encodes the bZIP transcription factor HBZ. (A) Organization of the HTLV-1 genome. The HTLV-1 provirus
genome (in kilobase pairs) is represented by a line. The viral genes encoded by the plus-strand RNA (white boxes) are shown above the genome
line (only the genes whose functions have been clearly established are represented). The HBZ gene encoded by the minus-strand RNA is
represented by a greyish box, below the line. (B) Comparison of the amino acid sequence of HBZ characterized from the HTLV-1-infected MT2
cell line with the HBZ protein from different HTLV-1 isolates. The amino acid sequence of MT2 HBZ is shown. The bZIP domain is underlined,
and the leucine residues within the leucine zipper are indicated by asterisks. Only differences in the other HTLV-1 isolates are indicated, while
homologies are represented by successive dashes. The different strains (with GenBank accession numbers in parentheses) are ATK-1 (J02029),
ATL-YS (U19949), RHK34 (L03562), WHP (AF259264), RK13-Ger (AF042071), BOI (L36905), HS-35 (D13784), and TSP1 (M86840).
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were purified as described by the manufacturer (Qiagen), dialyzed against bind-
ing buffer (see below) without bovine serum albumin (BSA), and kept at 80°C.
Streptavidin-biotin complex assay. Biotinylated oligonucleotides correspond-
ing to the HTLV-1 21-bp repeats TxRE III (5-TCGACGTCCTCAGGCGTTG
ACGACAACCCCTCAC-3) and somatostatin CRE (5-GGTTCCTCCTTGG
CTGACGTCAGAGAGAGA-3) were annealed with their complementary
oligonucleotides to form a double-stranded DNA. Biotinylated double-stranded
DNA was incubated with bacterially produced proteins in 200 l of binding
buffer containing 50 mM Tris (pH 7.5), 500 mM NaCl, 1 mM EDTA, 1 mM
dithiothreitol, 5 mM MgCl2, 0.1% Triton, 5% glycerol, and BSA (10 mg/ml) for
2 h at room temperature before addition of streptavidin beads (Pierce). After 1 h
of incubation at 4°C, the beads were extensively washed with binding buffer
without BSA. The proteins which remained bound to the beads were eluted in
sodium dodecyl sulfate (SDS) loading buffer and analyzed by Western blotting.
Immunoprecipitation and Western blot assays. Protein extracts were electro-
phoresed onto SDS–10% polyacrylamide gel (SDS-10% PAGE) and blotted to
polyvinylidene difluoride membranes (Millipore). The blot was then incubated
1 h at room temperature with a blocking solution (Tris-buffered saline containing
5% milk) prior to addition of antiserum. After 2 h at 20°C, the blot was washed
four times with Tris-buffered saline–0.2% Tween 20 and incubated for 1 h with
either donkey anti-goat, goat anti-mouse, or goat anti-rabbit immunoglobulin-
peroxidase conjugate. After three washes, the membrane was incubated with
enhanced chemiluminescence reagent (Amersham). The membrane was then
exposed for 0.5 to 5 min to Hyperfilms-ECL (Amersham). An immunoprecipi-
tation assay was carried out as already described (3, 31).
The anti-CREB-2 polyclonal serum was purchased from Santa Cruz Biotech-
nology Inc., Santa Cruz, Calif., and the anti-Tax monoclonal antibody was ob-
tained through the AIDS Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious Diseases, National Institutes
of Health; HTLV-1 Tax hybridoma 168A51-42 (Tab176) was obtained from B.
Langton. The anti-HBZ serum was obtained by immunizing rabbits with purified
six-His-tagged HBZ polypeptide corresponding to the bZIP domain of HBZ
expressed from the bacterial expression vector pQE-31 (Qiagen). The N-termi-
nal six-His-tagged protein was purified as described by the manufacturer.
RESULTS
The HTLV-1 genome encodes a bZIP transcription factor,
HBZ. CREB-2 is known to form heterodimers with other bZIP
transcription factors such as C/EBP (26), Nrf2 (13), and
CHOP (8). To identify other bZIP factors capable of interact-
ing with CREB-2, the CREB-2 bZIP (amino acids 263 to 351)
domain fused to the DNA-binding domain of LEXA was used
as bait to screen, by the yeast two-hybrid approach, a cDNA
library constructed from the HTLV-1-infected MT2 cell line by
Gachon et al. (9). Of 9  106 transformants, several colonies
positive for -galactosidase activity were isolated from histi-
dine-lacking plates. Two of these colonies contained the same
cDNA coding for the C terminus (amino acids 160 to 209) of
an unknown viral protein encoded by the complementary
strand of the HTLV-1 RNA genome (Fig. 1A) of all the
HTLV-1 isolates for which the sequences are accessible in the
GenBank data base (Fig. 1B). Comparison of the amino acid
sequence of this novel viral protein with databases revealed
that the sequence has several characteristics of a bZIP tran-
scription factor (Fig. 2). The C-terminal end contains one
isoleucine and four leucines, each separated by six other amino
acids, suggesting a leucine zipper structure (residues 164 to
192). Immediately upstream of this zipper sequence is an argi-
nine-lysine-rich basic domain (residues 140 to 163), thought to
be necessary for DNA binding by bZIP transcription factors.
To confirm that HBZ could be a transcriptional factor, the
yeast GAL4 DB domain was linked in frame to HBZ. GAL4-
HBZ was assayed in CEM cells by using the luciferase reporter
vector pG5luc that contains five GAL4-binding sites upstream
of a minimal TATA box. We found that GAL4-HBZ stimu-
lated the luciferase activity 43-fold (Fig. 3A). To map the
transcriptional activation domain within HBZ, we fused the
N-terminal (residues 1 to 122) or C-terminal (residues 123 to
209) regions to the GAL4 DB domain and measured luciferase
activation in cotransfected CEM cells. The N terminus gave
rise to a significant increase in reporter activity compared with
the GAL4 DB domain alone, since the luciferase activity was
overstimulated about 20-fold in the presence of the N-terminal
domain of HBZ (Fig. 3A). When a shorter N-terminal domain
of HBZ (residues 1 to 60) was fused to the GAL4 DB domain,
the luciferase activity was overstimulated about 600-fold. On
the other hand, the C terminus of HBZ was unable to activate
the luciferase expression (Fig. 3A). This result shows that HBZ
contains a potential transcriptional activation domain located
in the N terminus (residues 1 to 60). As shown in Fig. 3B, the
N-terminal domain of HBZ is a region rich in leucines (resi-
dues 9 to 53, 30% leucines) and acidic amino acids (residues 19
to 56, 46% acidic residues).
The bZIP family can be divided into three groups on the
basis of binding site preference: the C/EBPs (23), the AP1
group of transcription factors (33), and the CREB/ATF family
(25). To determine whether HBZ could belong to one of these
groups, HBZ activity was tested on luciferase reporter con-
structs carrying synthetic promoters corresponding to either
C/EBP, or AP-1, or CRE sites. However, HBZ was unable to
activate significantly transcription from these different sites
(data not shown), suggesting that HBZ could recognize unique
DNA sequences that are distinct from the tested sites.
Expression of HBZ in vivo. To raise polyclonal antibodies
against HBZ, two rabbits were immunized with highly purified
HBZ polypeptide corresponding to the last 87 amino acids of
HBZ. We studied the expression of HBZ in vivo with both
antisera by performing immunoprecipitation with anti-HBZ
from extracts of an HTLV-1-infected C8166 cell line. A protein
of 31 kDa, absent in extracts of uninfected cells, was detected
with both antisera but not with the preimmune sera (Fig. 4A
and B), the size of the detected protein being consistent with
the size of recombinant HBZ expressed by transient transfec-
FIG. 2. Comparison of the amino acid sequences of the basic do-
mains (at top; residues 140 to 164) and the leucine zipper structures (at
bottom; residues 164 to 193) of HBZ and several other bZIP tran-
scription factors. The conserved amino acids are indicated in boldface
type.
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tion in eukaryotic cell lines (data not shown). In addition, by
the same approach, we were able to detect HBZ also in MT4
cells that are infected by HTLV-1 too (Fig. 4C). These results
clearly show that HBZ is expressed in T cells infected by
HTLV-1. On the other hand, we were unable to detect HBZ by
this approach in extracts from the MT2 cell line (data not
shown), although the cDNA library screened by the two-hybrid
method was constructed from MT2 mRNA. However, this
inability to detect HBZ could be explained by a low level of
HBZ expression in the MT2 cells. Differences in the level of
viral protein expression between HTLV-1-infected cell lines
have already been reported for Tax (16) due to the presence of
defective proviruses. Thus, the profile of Tax in MT2 cells
corresponds to a weakly expressed authentic 40-kDa Tax but
also to a 69-kDa protein that is a fusion between the envelope
and the Tax-coding sequence (16).
Next, we investigated the subcellular localization of HBZ in
vivo. COS7 cells were transfected with vectors expressing HBZ
tagged with GFP, fused to the N-terminal end of HBZ. As
shown in Fig. 5, HBZ exhibits a granular distribution in the
nucleus. To be sure that the position and the size of the GFP
tag did not influence the HBZ localization, a smaller tag,
containing the myc epitope, was fused to the C-terminal end of
HBZ. In COS7 cells transfected with this construct, HBZ gives
the same staining pattern as that observed with the GFP tag
(data not shown). In addition, we fused to GFP a shorter form
of HBZ (residues 1 to 122) from which the bZIP domain had
been deleted. Indeed, the basic region of bZIP factors has been
described to be involved in the targeting of the protein to the
nucleus (2, 35). As shown in Fig. 5, this mutant exhibits a
staining pattern identical to that of the wild-type GFP, with a
diffuse distribution throughout the cytoplasm and the nucleus.
Taken together, these results demonstrate that HBZ is a nu-
clear protein and confirm that HBZ belongs to the family of
the bZIP transcription factors.
HBZ interacts with CREB-2 in vitro and in vivo. The phys-
ical interaction between HBZ and CREB-2 was first analyzed
in vitro using recombinant proteins. A fusion protein of
CREB-2 with glutathione S-transferase (GST) was produced
in E. coli, and the binding to [35S]methionine-labeled HBZ
that was produced in rabbit reticulocyte lysate was analyzed.
As shown in Fig. 6A, [35S]HBZ bound to GST-CREB-2 but not
to GST alone. In addition, [35S]HBZ bound to the CREB-2
bZIP domain fused to GST (Fig. 6A, lane GST-bZIP) but not
to GST-CREB-2 from which the bZIP domain had been de-
leted (Fig. 6A, lane GST-bZIP), confirming that CREB-2
interaction with HBZ is dependent on its bZIP domain. These
results demonstrate that HBZ can interact with CREB-2 in
vitro.
To confirm that both endogenous HBZ and CREB-2 were
also associated in vivo, immunoprecipitations of cell lysates of
HTLV-1-infected (C8166, MT2, and MT4) and uninfected
(Jurkat and CEM) cell lines were performed with anti-HBZ
serum, and the immunoprecipitates were probed by Western
blotting with a goat anti-CREB-2 serum. As expected, this
approach revealed the presence of a complex between HBZ
and CREB-2 in C8166 and MT4 extracts (Fig. 6B). On the
other hand, such a complex was not detected in the Jurkat,
CEM, and MT2 cell lines. Thus, this experiment demonstrates
that endogenous HBZ and CREB-2 interact in C8166 and
MT4 cell lines.
FIG. 3. The N terminus of HBZ contains a potent transcriptional activation domain. (A) CEM cells were cotransfected with 5 g of pAC1
(-galactosidase containing reference plasmid), 2 g of the luciferase reporter vector pG5luc, and 2 g of the eukaryotic vector pBIND expressing
the GAL4 DB domain alone or fused to either the full-length HBZ product (209 amino acids long), the N-terminal region (residues 1 to 122 and
1 to 60), or the C-terminal domain (residues 123 to 209). Luciferase values were normalized for -galactosidase activity and are expressed as
increases relative to that of cells transfected with pSG-5 and pBIND only expressing the GAL4 DB domain. Values are presented as means 
standard deviations (n 	 3). The GAL4-DB domain and the different regions of HBZ are represented by white and greyish boxes, respectively.
(B) Amino acid sequence of the HBZ N terminus (residues 1 to 60). The N terminus is rich in acidic and leucine residues (indicated in boldface
type in the sequence).
12816 GAUDRAY ET AL J. VIROL.
HBZ down-regulates the HTLV-1 transcription. CREB-2 is
known to function in association with Tax to trans-activate the
HTLV-1 transcription (9, 27) by forming a stable complex
CREB-2/Tax/CBP bound to the TxREs (10). For this reason,
we analyzed the effects of HBZ on the viral transcription by
cotransfecting CEM cells with a luciferase reporter construct
carrying the HTLV-1 promoter and increasing amounts of
pCI-HBZ in the presence of Tax expression vector pSG-Tax.
As shown in Fig. 7A, Tax alone activated expression of the
luciferase reporter gene by about 60-fold, but this stimulation
was inhibited in the presence of HBZ (only a 15-fold stimula-
tion). In order to be sure that this inhibition was not due to a
nonspecific effect of HBZ on cellular transcription, HBZ was
also tested in CEM cells with the HIV type 1 (HIV-1) pro-
moter in the presence of the HIV-1 activator Tat. Under these
conditions, HBZ did not down-regulate the HIV-1 transcrip-
tion stimulated by Tat (Fig. 7B), confirming that the decrease
in transactivation by HBZ from the HTLV-1 promoter in the
presence of Tax was specific. Thus, HBZ is able to downregu-
late the HTLV-1 transcription.
To determine whether the negative effect of HBZ on the
viral transcription might be mediated through an interaction
with CREB-2, we performed two different luciferase reporter
assays. We first analyzed by a transient-transfection assay per-
formed in CEM cells the ability of the HBZ bZIP domain to
inhibit the Tax transactivation of a synthetic promoter contain-
ing three tandem copies of the promoter-proximal TxRE. Ef-
fectively, the HBZ bZIP domain was able to down-regulate the
transcription in the presence of Tax (Fig. 7C), confirming that
an interaction between HBZ and endogenous CREB-2 could
be involved in this negative effect. Next, we analyzed the effects
of HBZ on the viral transcription by transfecting CEM cells
with either HBZ alone or in the presence of increasing
amounts of pCI-CREB-2. Interestingly, cotransfection of in-
creasing amounts of pCI-CREB-2 resulted in a significant in-
crease in luciferase activity (Fig. 7D). Lastly, we also checked
that HBZ was unable to interact with Tax (data not shown).
Taken together, our results suggest that HBZ is able to down-
regulate the HTLV-1 transcription by interacting with
CREB-2.
Recently, we have demonstrated that the cellular bZIP tran-
scription factor CHOP was capable of inhibiting the HTLV-1
transcription (8), probably by forming heterodimers with
CREB-2 that are unable to bind to the TxREs. In light of these
results, we tested whether dimerization between HBZ and
CREB-2 results in a heterodimer unable to bind to the cellular
CRE consensus site. For this purpose, we used the streptavi-
din-biotin complex assay previously used by Gachon et al. for
the characterization of the complexes formed among CREB-2,
Tax, and TxREs (10). A double-stranded oligonucleotide cor-
responding to the somatostatin CRE was incubated with
CREB-2 in the absence or in the presence of the bZIP domain
of HBZ. CREB-2 alone bound to CRE (Fig. 8, lane 2), but in
FIG. 4. Detection of HBZ in vivo by immunoprecipitation. Pro-
teins were immunoprecipitated from the lysate of either the HTLV-
1-infected T-cell line C8166 or the uninfected T-cell line CEM using
preimmune sera (PI) or the anti-HBZ sera (I) produced by two dif-
ferent rabbits (A and B). Precipitates were analyzed by SDS-PAGE
and immunoblotting with anti-HBZ serum. The molecular mass mark-
ers (in kilodaltons) are indicated on the right of the figure. (C) The
same approach was carried out from the lysate of the HTLV-1-infected
MT4 cell line using preimmune serum (PI) or the anti-HBZ serum (I).
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the presence of HBZ bZIP, CREB-2 interaction with CRE was
inhibited (Fig. 8, lanes 3 and 4). We then asked whether HBZ
also affects the binding of CREB-2 and Tax to the HTLV-1
TxRE III site (10). As shown in Fig. 8 (lanes 7 and 8), HBZ
bZIP abolished the binding of CREB-2 and Tax to the TxRE
site. In addition, by the same approach, we found that HBZ
was unable to bind directly to the CRE and TxRE motifs (data
not shown). In conclusion, our results demonstrate that HBZ
inhibits CREB-2 from binding to CRE and the related TxRE
site.
DISCUSSION
In this paper, we describe the identification of a novel viral
bZIP factor, which we have named HBZ and which is encoded
by the complementary strand of the HTLV-1 RNA genome.
The HBZ gene is exactly located between the env and tax/rex
genes of the HTLV-1 genome. Comparison of the HBZ amino
acid sequence of different HTLV-1 isolates revealed that HBZ
sequence is highly conserved (between 96 and 100% identity
depending on the compared isolates), with a very high degree
of conservation in the key domains such as the activation and
bZIP domains. In addition, Larocca et al. have shown that the
HBZ gene is transcribed from a promoter present in the 3
terminus of the HTLV-1 provirus (22). By RNA blotting
probed with single-stranded radiolabeled RNA, they charac-
terized 2.5- and 2.9-kb minus-strand RNAs encompassing the
HBZ gene. These RNAs accumulate in the HTLV-1-infected
SLB1 cell line and are absent in uninfected cells (22). In this
work, we have characterized the HBZ protein by using an
immunological approach in two other HTLV-1-infected T-cell
lines, C8166 and MT4. On the other hand, we were unable to
detect HBZ protein in the MT2 cell line, probably due to a low
expression of HBZ in these cells. Indeed, the abundance of
HBZ-minus RNA in infected cells has been estimated to be
1/50 to 1/100 of the abundance of the Tax-plus RNA (22).
Thus, taken together, these results clearly demonstrate that
HBZ is a bona fide HTLV-1-encoded protein.
The HBZ gene is also present in the simian T-cell leukemia
virus type 1 genome but does not exist in the genomes of
HTLV-2 and BLV. Interestingly, HTLV-2 has not yet been
proven to be the causative agent of any specific hematological
FIG. 5. Immunofluorescence microscopy analysis of the subcellular localization of HBZ with an N-terminal GFP tag in vivo. COS7 cells were
transfected with expression vectors encoding either GFP-HBZ (A and B), GFP (C), or GFP-HBZbZIP (D). Cells were cultivated on the glass
slides, fixed, and stained with Hoechst solution, and then the green fluorescence was analyzed by immunofluorescence microscopy. The specificity
of the immunofluorescent staining is indicated by the absence of signal in flanking untransfected cells. The blue fluorescence of the nuclei (Hoechst
staining) is visualized by UV illumination.
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disease, whereas BLV is involved in the development of B-cell
lymphomas. This is the first time that the characterization of an
HTLV-1 protein encoded by a minus-strand gene has been
reported. An important aspect of our findings is to know
whether such a minus-strand gene can also exist in the proviral
genome of other retroviruses. In the case of the HIV-1 proviral
genome, the existence of an antisense RNA encoding a protein
with an apparent molecular mass of 19 kDa has been described
previously (34), but the function of this protein has not been
characterized until now. In the future, characterization of such
hidden genes should allow us to better understand the molec-
ular and cellular mechanisms involved in the development of
the pathologies associated with the retroviruses.
We demonstrate here that HBZ can interact in vitro and in
vivo with another bZIP protein, the cellular factor CREB-2,
that has been described to function (9, 27) in association with
Tax to trans-activate the transcription of the HTLV-1 genome.
We show that, in the presence of HBZ, CREB-2 is no longer
able to activate the transcription from the viral TxREs because
the HBZ/CREB-2 heterodimer is unable to bind to the TxRE
motif. Recently, we have demonstrated that the heterodimer-
ization of CREB-2 with the cellular bZIP factor CHOP also
down-regulates the HTLV-1 transcription (8). Thus, although
CREB-2 is known to form heterodimers in vivo with other
bZIP transcription factors, CREB-2 homodimerization, prob-
ably guided by Tax (1, 18, 36), seems to be necessary to activate
the viral transcription. Consequently, CREB-2 heterodimer-
ization represents a powerful means to regulate negatively the
HTLV-1 transcription. However, CREB-2 is not the only bZIP
factor cooperating with Tax to stimulate the HTLV-1 tran-
scription, since CREB and CREM have also been suggested to
be involved in the viral expression (4, 29, 37, 38). Preliminary
data obtained by in vitro binding assays (G. Gaudray, unpub-
lished results) suggest that HBZ is capable of interacting with
CREB too. Of course, complementary approaches should be
investigated further to clearly demonstrate whether HBZ
could also inhibit CREB from binding to the HTLV-1 pro-
moter. Moreover, our results suggest that balance between the
production of Tax and HBZ could be involved in the regula-
tion of the HTLV-1 transcription in the infected T cells. Pro-
duction of Tax is necessary to promote the proliferation of cells
infected by HTLV-1, but Tax is also responsible for a strong
cytotoxic-T-lymphocyte response to HTLV-1-infected cells. By
FIG. 6. HBZ interacts with CREB-2. (A) In vitro binding assays of HBZ to CREB-2. Equal amounts of GST, GST-CREB-2, GST-CREB-
2263-351 (lane GST-bZIP), and GST-CREB-21-262 (lane GST-bZIP) immobilized on glutathione-Sepharose beads were incubated with [
35S]HBZ,
and bound proteins were analyzed by SDS-PAGE and autoradiography. The first lane corresponds to in vitro-translated [35S]HBZ. (B) Binding
of HBZ to CREB-2 in vivo. Proteins from MT4, MT2, C8166, CEM, and Jurkat cell total lysate were immunoprecipitated with rabbit anti-HBZ
(I.P. 
HBZ), and immunoprecipitated proteins were analyzed by immunoblotting with goat anti-CREB-2 (I.B. 
CREB-2).
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FIG. 7. HBZ down-regulates the HTLV-1 transcription by interacting with CREB-2. CEM cells were cotransfected with the following: (A) 2
g of HTLV-1 LTR-luciferase, 1 g of Tax expression vector pSG-Tax, and pCI-HBZ (0, 1, 3, or 9 g) (the luciferase values are expressed as
increases relative to that of cells transfected with pSG-5, pCI-neo, and HTLV-1 LTR-luciferase); (B) 2 g of HIV-1 LTR-luciferase, 1 g of the
Tat expression vector pBg312HIV-1Lai-Tat, and pCI-HBZ (0, 1, 3, or 9 g) (the luciferase values are expressed as increases relative to that of cells
transfected with HIV-1 LTR-luciferase without Tat and HBZ); (C) 2 g of HTLV-1 TxRE-luciferase, 1 g of pSG-Tax, and 5 g of pCI-neo
expressing either HBZ or the HBZ bZIP domain (the luciferase values are expressed as increases relative to that of cells transfected with pSG-5,
pCI-neo, and HTLV-1 TxRE-luciferase); (D) 2 g of HTLV-1 TxRE-luciferase, 1 g of pSG-Tax, 5 g of pCI-HBZ, and pCI-CREB-2 (0, 1, 3,
or 9 g) (the luciferase values are expressed as fold increase relative to that of cells transfected with pSG-5, pCI-neo, and HTLV-1
TxRE-luciferase). For all the cotransfections, the total amount of DNA in each series of transfection was equal, the balance being made up
with empty plasmids. and the luciferase values were normalized for -galactosidase activity. Values represent means plus standard deviations
(error bars) (n 	 3).
12820 GAUDRAY ET AL J. VIROL.
down-regulating the viral transcription, infected cells express-
ing HBZ could escape the cytotoxic-T-lymphocyte response.
HBZ obviously is not involved in only the down-regulation
of the HTLV-1 transcription. Given the presence of an activa-
tion domain in its N-terminal domain, HBZ is likely to func-
tion as a trans-activator by binding enhancer motifs through
homo- or heterodimer formation. In this perspective, recent
results obtained in our laboratory by a yeast two-hybrid screen-
ing of the MT2 cDNA bank with HBZ show the existence of
interactions between HBZ and other bZIP factors than
CREB-2 (J. Basbous, unpublished data). From these observa-
tions, it is tempting to speculate that HBZ could mediate its
trans-activation function through binding to promoters of cel-
lular genes and disturb the normal expression of these genes.
Moreover, Marek’s disease virus, which is one of the most
potent oncogenic avian herpesvirus, also encodes a bZIP fac-
tor, the MEQ protein (19). Marek’s disease virus induces the
rapid onset of T-cell lymphoma and a demyelinating disease,
and MEQ has been suggested to be involved in the oncogenic
process (24). Experiments are under way to further evaluate
the possibility that HBZ could also be involved in the onco-
genic process of the transformation of the HTLV-1-infected
T-cells.
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